951 related articles for article (PubMed ID: 27165166)
1. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
2. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
3. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?
Barrea L; Balato N; Di Somma C; Macchia PE; Napolitano M; Savanelli MC; Esposito K; Colao A; Savastano S
J Transl Med; 2015 Jan; 13():18. PubMed ID: 25622660
[TBL] [Abstract][Full Text] [Related]
4. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
[TBL] [Abstract][Full Text] [Related]
5. Coffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff?
Barrea L; Muscogiuri G; Di Somma C; Annunziata G; Megna M; Falco A; Balato A; Colao A; Savastano S
Arch Toxicol; 2018 May; 92(5):1831-1845. PubMed ID: 29594327
[TBL] [Abstract][Full Text] [Related]
6. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
7. Effect of CoQ10 Administration to Psoriatic Iraqi Patients on Biological Therapy Upon Severity Index (PASI) and Quality of Life Index (DLQI) Before and After Therapy.
Al-Oudah GA; Sahib AS; Al-Hattab MK; Al-Ameedee AA
J Popul Ther Clin Pharmacol; 2022; 29(2):e52-e60. PubMed ID: 35848197
[TBL] [Abstract][Full Text] [Related]
8. Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.
Evyana D; Novianto E; Budianti WK; Krisanti RIA; Wisnu W; Wibawanti R; Nilasari H; Legiawati L; Hapsari SAR; Mutmainnah E
PLoS One; 2024; 19(4):e0302391. PubMed ID: 38683749
[TBL] [Abstract][Full Text] [Related]
9. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
[TBL] [Abstract][Full Text] [Related]
10. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments.
Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chaweekulrat P
J Dermatol; 2016 Dec; 43(12):1424-1428. PubMed ID: 27511608
[TBL] [Abstract][Full Text] [Related]
12. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis.
Puig L; Thom H; Mollon P; Tian H; Ramakrishna GS
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):213-220. PubMed ID: 27739123
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis Severity-A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome.
Polic MV; Miskulin M; Smolic M; Kralik K; Miskulin I; Berkovic MC; Curcic IB
Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 30011841
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome prevalence in psoriasis: a cross-sectional study in the Italian population.
Parodi A; Aste N; Calvieri C; Cantoresi F; Carlesimo M; Fabbri P; Filosa G; Galluccio A; Lisi P; Micali G; Potenza C; Richetta A; Simonacci M; Trevisan P; Valenti G; Calvieri S
Am J Clin Dermatol; 2014 Aug; 15(4):371-7. PubMed ID: 24756247
[TBL] [Abstract][Full Text] [Related]
15. Phase Angle: A Possible Biomarker to Quantify Inflammation in Subjects with Obesity and 25(OH)D Deficiency.
Barrea L; Muscogiuri G; Laudisio D; Di Somma C; Salzano C; Pugliese G; de Alteriis G; Colao A; Savastano S
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31362440
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis beyond the skin surface: a pilot study on the ocular involvement.
Campanati A; Neri P; Giuliodori K; Arapi I; Carbonari G; Borioni E; Herbort CP; Mariotti C; Giovannini A; Offidani A
Int Ophthalmol; 2015 Jun; 35(3):331-40. PubMed ID: 24799345
[TBL] [Abstract][Full Text] [Related]
17. Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.
Khawaja AR; Bokhari SM; Tariq R; Atif S; Muhammad H; Faisal Q; Jafferany M
Prim Care Companion CNS Disord; 2015; 17(3):. PubMed ID: 26644955
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis and the metabolic syndrome.
Gisondi P; Fostini AC; Fossà I; Girolomoni G; Targher G
Clin Dermatol; 2018; 36(1):21-28. PubMed ID: 29241748
[TBL] [Abstract][Full Text] [Related]
19. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome.
Liu P; Ma F; Lou H; Liu Y
BMC Public Health; 2013 Jul; 13():629. PubMed ID: 23819808
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
